Works in Hematological Oncology, 2023, Vol 41
Results: 861
Early intervention of extracorporeal photopheresis for advancing/progressing cutaneous T‐cell lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 809, doi. 10.1002/hon.3229
- By:
- Publication type:
- Article
Correction to Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant‐ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 954, doi. 10.1002/hon.3226
- Publication type:
- Article
Evaluation of the novel therapeutic anti‐CCR7 antibody CAP‐100 as an add‐on therapy in chronic lymphocytic leukemia patients receiving venetoclax.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 869, doi. 10.1002/hon.3213
- By:
- Publication type:
- Article
TNFRSF13B gene mutation in familial acute myeloid leukemia: A new piece in the complex scenario of hereditary predisposition?
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 942, doi. 10.1002/hon.3212
- By:
- Publication type:
- Article
Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T‐cell pathway in patients with diffuse large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 947, doi. 10.1002/hon.3211
- By:
- Publication type:
- Article
Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL‐102): A phase 1 study.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 848, doi. 10.1002/hon.3209
- By:
- Publication type:
- Article
Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 912, doi. 10.1002/hon.3208
- By:
- Publication type:
- Article
Magnesium enhances the graft‐versus‐tumor effect of donor lymphocytic infusion on hematologic malignancies.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 922, doi. 10.1002/hon.3207
- By:
- Publication type:
- Article
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS‐CoV‐2 infection.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 904, doi. 10.1002/hon.3206
- By:
- Publication type:
- Article
Ultrasonography‐guided core‐needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front‐line biopsies in a multicenter Italian study.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 817, doi. 10.1002/hon.3204
- By:
- Publication type:
- Article
The course of patients with hairy cell leukemia during the omicron surge of the Covid‐19 pandemic.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 894, doi. 10.1002/hon.3203
- By:
- Publication type:
- Article
The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 951, doi. 10.1002/hon.3201
- By:
- Publication type:
- Article
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 877, doi. 10.1002/hon.3199
- By:
- Publication type:
- Article
A retrospective study of 222 patients with newly diagnosed primary central nervous system lymphoma—Outcomes indicative for improved survival overtime.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 838, doi. 10.1002/hon.3198
- By:
- Publication type:
- Article
Combined treatment with crizotinib and temsirolimus is an effective strategy in mantle cell lymphoma and can overcome acquired resistance to temsirolimus.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 858, doi. 10.1002/hon.3194
- By:
- Publication type:
- Article
A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 884, doi. 10.1002/hon.3192
- By:
- Publication type:
- Article
Primary testicular lymphoma demonstrates overexpression of the Wilms tumor 1 gene and different mRNA and miRNA expression profiles compared to nodal diffuse large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 828, doi. 10.1002/hon.3190
- By:
- Publication type:
- Article
Early granulocyte colony stimulating factor administration increases the risk of cytokine release syndrome in acute lymphoblastic leukemia patients receiving anti‐CD19 chimeric antigen receptor T‐cell therapy.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 933, doi. 10.1002/hon.3188
- By:
- Publication type:
- Article
Unmet clinical needs in the use of zanubrutinib in malignant lymphomas (Waldenström macroglobulinemia, marginal zone lymphoma and mantle cell lymphoma): A consensus‐based position paper from an ad hoc expert panel.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 795, doi. 10.1002/hon.3172
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 793, doi. 10.1002/hon.3022
- Publication type:
- Article
Reducing the risks of nuclear war—The role of health professionals.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 605, doi. 10.1002/hon.3218
- By:
- Publication type:
- Article
Increased neopterin in cerebrospinal fluid in active adult neurohistiocytosis.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 762, doi. 10.1002/hon.3189
- By:
- Publication type:
- Article
Molecular classification and identification of an aggressive signature in low‐grade B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 644, doi. 10.1002/hon.3187
- By:
- Publication type:
- Article
The effect of haploidentical hematopoietic stem cell transplantation on comutations based on next‐generation sequencing in adult acute myeloid leukemia patients with the FLT3‐ITD mutation.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 733, doi. 10.1002/hon.3186
- By:
- Publication type:
- Article
Intravenous immunoglobulin prophylaxis is associated with decreased rate of infection‐related hospitalizations in multiple myeloma patients.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 718, doi. 10.1002/hon.3185
- By:
- Publication type:
- Article
Impact of immunochemotherapy with R‐bendamustine or R‐CHOP for treatment naïve advanced‐stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 655, doi. 10.1002/hon.3184
- By:
- Publication type:
- Article
Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 663, doi. 10.1002/hon.3174
- By:
- Publication type:
- Article
Mortality in COVID‐19 hospitalizations with underlying hematologic malignancies in the United States.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 781, doi. 10.1002/hon.3173
- By:
- Publication type:
- Article
[<sup>18</sup>F]‐FDG PET radiomic model as prognostic biomarker in diffuse large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 674, doi. 10.1002/hon.3171
- By:
- Publication type:
- Article
Report of PRPF19 as a novel partner of RARG and the recurrence of interposition‐type fusion in variant acute promyelocytic leukemia.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 784, doi. 10.1002/hon.3170
- By:
- Publication type:
- Article
Patients with secondary acute myeloid leukemia undergoing allogeneic stem‐cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 753, doi. 10.1002/hon.3160
- By:
- Publication type:
- Article
A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 743, doi. 10.1002/hon.3159
- By:
- Publication type:
- Article
Revisiting the predictive role of 18F‐fluorodeoxyglucose positron emission tomography/computerized tomography on treatment outcome in early‐stage favorable Hodgkin lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 608, doi. 10.1002/hon.3158
- By:
- Publication type:
- Article
LncRNA FEZF1‐AS1 accelerates multiple myeloma progression by regulating IGF2BP1/BZW2 signaling.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 694, doi. 10.1002/hon.3157
- By:
- Publication type:
- Article
Significant reduction in the incidence of non‐coronavirus infections in patients with chronic lymphocytic leukemia on ibrutinib and venetoclax treatment during the COVID‐19 pandemic: An additional benefit of lockdown.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 683, doi. 10.1002/hon.3156
- By:
- Publication type:
- Article
A comprehensive analysis of coagulopathy during anti‐B cell maturation antigen chimeric antigen receptor‐T therapy in multiple myeloma, a retrospective study based on LEGEND‐2.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 704, doi. 10.1002/hon.3155
- By:
- Publication type:
- Article
A five‐gene signature may associate with central nervous system dissemination in adult acute lymphoblastic leukemia.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 789, doi. 10.1002/hon.3136
- By:
- Publication type:
- Article
Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 725, doi. 10.1002/hon.3135
- By:
- Publication type:
- Article
Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization results.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 771, doi. 10.1002/hon.3134
- By:
- Publication type:
- Article
Whole exome sequencing of primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorders.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 768, doi. 10.1002/hon.3133
- By:
- Publication type:
- Article
Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 631, doi. 10.1002/hon.3132
- By:
- Publication type:
- Article
Treatment intensification might not improve survival in high‐grade B‐cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 776, doi. 10.1002/hon.3130
- By:
- Publication type:
- Article
Myelodysplastic syndromes with ring sideroblasts.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 612, doi. 10.1002/hon.3125
- By:
- Publication type:
- Article
Real‐world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 621, doi. 10.1002/hon.3122
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 603, doi. 10.1002/hon.3021
- Publication type:
- Article
Long‐term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 407, doi. 10.1002/hon.3131
- By:
- Publication type:
- Article
Chemoresistance in acute myeloid leukemia: An alternative single‐cell RNA sequencing approach.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 499, doi. 10.1002/hon.3129
- By:
- Publication type:
- Article
Risk of a second cancer and infection in patients with indolent B‐cell lymphoma exposed to first‐line bendamustine plus rituximab: A retrospective analysis of an administrative claims database.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 354, doi. 10.1002/hon.3128
- By:
- Publication type:
- Article
COVID‐19 does not impact on outcome of myeloma patients infected while undergoing autologous stem cell transplantation.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 555, doi. 10.1002/hon.3127
- By:
- Publication type:
- Article
Predictors of ibrutinib‐associated atrial fibrillation: 5‐year follow‐up of a prospective study.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 363, doi. 10.1002/hon.3126
- By:
- Publication type:
- Article